QP 13 - GU 7: Quick Pitch: Optimizing Treatment of Recurrent Prostate Cancer

Presentations

• 04:00pm - 04:05pm PT

  Introduction

  Speaker: Sean McBride, MD - Memorial Sloan Kettering Cancer Center, New York
• 04:05pm - 04:10pm PT

  Interim Analysis of a Phase 2 Single Arm Trial of Extended Lymph Node Proton Irradiation for High Risk Prostate Cancer

  Speaker: Pretesh Patel, MD - Emory University School of Medicine, Atlanta
• 04:10pm - 04:15pm PT

  Second-Line Radiation Therapy for Locally Recurrent Prostate Cancer after Focal Therapy: A Single Institution Matched-Pair Analysis

  Speaker: Nikitha Kalahasti, BS - Stanford University, San Jose
• 04:15pm - 04:20pm PT

  Implications on Radiation Treatment Planning of 18F-Fluciclovine PET/CT in Patients with Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET/CT

  Speaker: Adam Eakin, MD - Oregon Health and Science University, Portland
• 04:20pm - 04:25pm PT

  Analysis on the Predictive Power of PSA-Nadir <0.1 ng/ml after Salvage Radiotherapy for PSA-Recurrence after Radical Prostatectomy - Subanalysis of the Phase-III Dose Escalation SAKK 09/10 Study and Comparison with a Retrospective Cohort

  Speaker: Thomas Wiegel, MD - University Hospital Ulm, Ulm
• 04:25pm - 04:30pm PT

  Early Results from a Randomized Phase II Trial Testing Apalutamide and Stereotactic Body Radiation Therapy for Low-Burden Mhspc (NCT05717660)

  Speaker: Giulio Francolini, MD - Azienda Ospedaliera Universitaria Careggi, Firenze
• 04:30pm - 04:35pm PT

  A Dynamic Treatment Strategy for Oligometastatic CSPC: Integrating Molecular Imaging and SBRT to Personalize Systemic Therapy Intensification and De-Intensification

  Speaker: Piero Bettoli, MD, MS - Instituto Nacional del Cancer, Santiago
• 04:35pm - 04:55pm PT

  Question and Answers

  Speaker: Matthew Ward, MD - Levine Cancer Institute, Charlotte
• 04:55pm - 05:00pm PT

  Closing

  Speaker: Sean McBride, MD - Memorial Sloan Kettering Cancer Center, New York